Differential regulation of activation-induced cell death in individual human T cell clones

International Archives of Allergy and Immunology

Volumn 121, Issue 3, 2000, Pages 183-193

  Janssen, Ottmar ^a   Stocker, Andreas ^b   Sanzenbacher, Ralf ^b   Oberg, Hans Heinrich ^a   Siddiqi, Mushtaq A ^c   Kabelitz, Dieter ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b PAUL EHRLICH INSTITUT   (Germany)

^c SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Activation induced cell death; Apoptosis; CD95; Signal transduction; T cell receptor; T helper cells; T lymphocytes

Indexed keywords

FAS LIGAND; MESSENGER RNA; PHOSPHATASE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LYMPHOCYTE CLONE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0034018781     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024316     Document Type: Article

References (43)

1. Nagata S, Golstein P: The Fas death factor. Science 1995;267:1449-1456.
2. Krammer PH: CD95(APO-1/Fas)-mediated apoptosis: Live and let die. Adv Immunol 1999;71:163-210.
3. Janssen O, Wesselborg S, Heckl-Östreicher B, Pechold K, Bender A, Schondelmaier S, Moldenhauer G, Kabelitz D: T cell receptor/CD3-signaling induces death by apoptosis in human T cell receptor γδ+ T cells. J Immunol 1991;146:35-39.
4. Wesselborg S, Janssen O, Kabelitz D: Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J Immunol 1993;150:4338-4345.
5. Wesselborg S, Prüfer U, Wild M, Schraven B, Meuer SC, Kabelitz D: Triggering via the alternative CD2 pathway induces apoptosis in activated human T lymphocytes. Eur J Immunol 1993;23:2707-2710.
6. Kabelitz D, Janssen O: Antigen-induced death of T-lymphocytes. Front Biosci 1997;2:61-77.
7. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Goodwin RG, Smith CA, Ramsdell F, Lynch DH: Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 1995;181:71-77.
8. Dhein J, Walczak H, Bacumler C, Debatin KM, Krammer PH: Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 1995;373:438-441.
9. Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Green DR: Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995;373:441-444.
10. Ju ST, Panka DJ, Cui H, Ettinger R, el-Khatib M. Sherr DH, Stanger BZ, Marshak-Rothstein A: Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995;373:444-448.
11. Russel JH: Activation-induced death of mature T cells in the regulation of immune responses. Curr Opin Immunol 1995;7:382-388.
12. Peter ME, Krammer PH: Mechanisms of CD95(APO-1/Fas)-mediated apoptosis. Curr Opin Immunol 1998;10:545-551.
13. Migita K, Eguchi K, Yojiro K, Mizokami A, Tsukada T, Nagata S: Prevention of anti-CD3 monoclonal antibody-induced thymie apoptosis by protein tyrosine kinase inhibitors. J Immunol 1994;153:3457-3465.
14. Orchansky PL, Teh H-S: Activation-induced cell death in proliferating T cells is associated with altered tyrosine phosphorylation of TCR/ CD3 subunits. J Immunol 1994;153:615-622.
15. Anel A, Buferne M, Boyer C, Schmitt-Verhulst AM, Golstein P: T cell receptor-induced CD95 ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur J Immunol 1994;24:2469-2476.
16. lck in T-cell receptor/CD3-mediated apoptosis and Fas-ligand induction in Jurkat cells. Biochem Biophys Res Commun 1995;213:994-1001.
17. Vignaux F, Vivier E, Malissen B, Depractere V, Nagata S, Golstein P: TCR/CD3 coupling to Fas-based cytotoxicity. J Exp Med 1995;181:781-786.
18. Oberg HH, Lengl-Janssen B, Robertson MJ, Kabelitz D, Janssen O: Differential role of tyrosine phosphorylation in the induction of apoptosis in T cell clones via CD95 or the TCR/ CD3-complex. Cell Death Differ 1997;4:403-412.
19. Oberg HH, Sanzenbacher R, Lengl-Janssen B, Dobmeyer T, Flindt S, Janssen O, Kabelitz D: Ligation of cell surface CD4 inhibits activation-induced death of human T lymphocytes at the level of Fas ligand expression. J Immunol 1997;159:5742-5749.
20. lck: A role for SLP-76 in CD4-induced desensitization of the TCR/CD3 signaling complex. J Immunol 1999;163:3143-3152.
21. Ramsdell F, Seaman MS, Miller RE, Picha KS, Kennedy MK, Lynch DH: Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. Int Immunol 1994;6:1545-1553.
22. Oberg HH, Lengl-Janssen B, Kabelitz D, Janssen O: Activation-induced T cell death: Resistance or susceptibility correlate with cell surface Fas ligand expression and T helper phenotype. Cell Immunol 1997;181:93-100.
23. Accornero P, Radrizzani M, Delia D, Gerosa F, Kurrle R, Colombo MP: Differential susceptibility to HIV-GP120-sensitized apoptosis in CD4+ T cell clones with different T-helper phenotypes: Role of CD95/CD95L interactions. Blood 1997;89:558-569.
24. Zhang X, Brunner T, Carter L, Dulton RW, Rogers P, Bradley L, Sato T, Reed JC, Green D, Swain S: Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apotosis. J Exp Med 1997;185:1837-1847.
25. Varadhachary AS, Perdow SN, Hu C, Ramanarayanan M, Salgame P: Differential ability of T cell subsets to undergo activation-induced cell death. Proc Natl Acad Sci USA 1997;94:5778-5783.
26. Estaquier J, Idziorek T, Zou W, Emilie D, Farber C-M, Bourez J-M, Ameisen JC: T helper type 1/T helper type 2 cytokines and T cell death: Preventive effect of interleukin 12 on activation-induced and CD95 (Fas/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons. J Exp Med 1995;182:1759-1767.
27. Sato T, Irie S, Kitada S, Reed JC: FAP-1: A protein tyrosine phosphatase that associates with Fas. Science 1995;268:411-415.
28. Wesselborg S, Janssen O, Pechhold K, Kabelitz D: Selective activation of γ/β+ T cell clones by single anti-CD2 antibodies. J Exp Med 1991;173:297-304.
29. Smith D, Sieg S, Kaplan D: Technical note: Aberrant detection of cell surface Fas ligand with anti-peptide antibodies. J Immunol 1998;160:4159-4160.
30. Sallusto F, Lenig D, Mackay CR, Lanzavecehia A: Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998;187:875-883.
31. Janssen O, Scheffler A, Kabelitz D: In vitro effects of mistletoe extracts and mistletoe lectins. Cytotoxicity towards tumor cells due to the induction of programmed cell death (apoptosis). Drug Res 1993;43:1221-1227.
32. Janssen O, Lengl-Janssen B, Oberg HH, Robertson MJ, Kabelitz D: Induction of cell death via Fas (CD95, APO-1) may be associated with but is not dependent on Fas-induced tyrosine phosphorylation. Immunol Lett 1996;49:63-69.
33. Mosmann TR, Coffman RL: TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-173.
34. Muñoz E, Zubiaga AM, Merrow M, Sauter NP, Huber BT: Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: Role of cAMP in T cell proliferation. J Exp Med 1990;172:95-103.
35. Gajewski TF, Pinnas M, Wong T, Fitch FW: Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations. J Immunol 1991;146:1750-1758.
36. Sallusto F, Lanzavecehia A, Mackay CR: Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 1998;19:568-574.
37. Suda T, Takahashi T, Brannan CI, Nagata S: Molecular cloning and expression of the Fas ligand: A novel member of the tumor necrosis factor family. Cell 1993;75:1169-1178.
38. Suda T, Okazaki T, Naizo Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S: Expression of the Fas ligand in cells of T cell lineage. J Immunol 1995;154:3806-3813.
39. Watanabe N, Arase H, Kurasawa K, Iwamoto I, Kayagaki N, Yagita H, Okumura K, Miyatake S, Saito T: Th1 and Th2 subsets equally undergo Fas-dependent and - independent activation-induced cell death. Eur J Immunol 1997;27:1858-1864.
40. Cuppen E, Nagata S, Wieringa B, Hendriks W: No evidence for involvement of mouse protein-tyrosine phosphatase-BAS-like Fas-associated phosphatase-1 in Fas-mediated apoptosis. J Biol Chem 1997;272:30215-30220.
41. Tanaka M, Itai T, Adachi M, Nagata S: Downregulation of Fas ligand by shedding. Nat Med 1998;4:31-36.
42. Schneider P, Holler N, Bodmer JL, Hahne M, Frei K, Fontana A, Tschopp J: Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med 1998;187:1205-1213.
43. Moskophidis D, Lechner F, Pircher H, Zinkernagel RM: Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 1993;362:758-761.